Related Experiment Video

Updated: May 9, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients

B Vrtovec1, G Poglajen, M Sever

  • 11] Department of Cardiology, Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Ljubljana, Slovenia [2] Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.

Clinical Pharmacology and Therapeutics
|August 2, 2013
PubMed

Insights

CD34(+) stem cell therapy shows promise for nonischemic dilated cardiomyopathy, a large heart failure group needing new treatments. This review explores its long-term effects and mechanisms for improving blood flow.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Therapy

Background:

  • Nonischemic dilated cardiomyopathy is the largest heart failure subpopulation requiring novel treatments.
  • Myocardial regions with flow abnormalities in this group may benefit from neoangiogenic therapies.
  • CD34(+) stem cells are investigated for their potential to promote new blood vessel formation.

Purpose of the Study:

  • To review the long-term clinical effects of CD34(+) stem cell therapy in nonischemic dilated cardiomyopathy.
  • To summarize the potential underlying mechanisms of CD34(+) stem cell therapy in this patient population.

Main Methods:

  • Review of existing literature on CD34(+) stem cell therapy for nonischemic dilated cardiomyopathy.
  • Analysis of clinical outcomes and proposed biological mechanisms.

Main Results:

  • CD34(+) stem cells may enhance vascularization through direct incorporation or cytokine secretion.
  • Potential for improved myocardial perfusion and cardiac function.

Conclusions:

  • CD34(+) stem cell therapy presents a potential therapeutic strategy for nonischemic dilated cardiomyopathy.
  • Further research is warranted to fully elucidate the long-term benefits and mechanisms.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...